Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Edward M. Kaye Md currently holds 10,365 shares of Sarepta Therapeutics, Inc. (SRPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Edward M. Kaye Md has been a net seller of SRPT stock. They have purchased $9.5K and sold $17.7M worth of shares.
Edward M. Kaye Md's most recent insider trade was on Apr 15, 2026, when they sold 191 shares at $65.37 per share.
Edward M. Kaye Md serves as Executive at Sarepta Therapeutics, Inc. (SRPT). They have executed 105 insider transactions totaling $17.7M over their tenure at the company.
Edward M. Kaye Md holds the position of Executive at Sarepta Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Edward M. Kaye Md has shown a selling trading pattern, with $9.5K in total purchases and $17.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Edward M. Kaye Md was on Dec 1, 2025, when they sold $1.9M worth of CYTK shares. This transaction involved 28,064 shares at $66.72 per share.
Edward M. Kaye Md currently owns 10,365 shares of Sarepta Therapeutics, Inc. (SRPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Edward M. Kaye Md's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Edward M. Kaye Md has 105 Form 4 filings on record as an insider at Sarepta Therapeutics, Inc..
Set alerts for Edward M. Kaye Md and 40,000+ other insiders.